Peroxiredoxin Expression of Human Osteosarcoma Cells Is Influenced by Cold Atmospheric Plasma Treatment

Anticancer Res. 2017 Mar;37(3):1031-1038. doi: 10.21873/anticanres.11413.

Abstract

Background/aim: To evaluate the potential involvement of redox-specific signalling pathways in cold atmospheric plasma (CAP)-induced apoptosis on human osteosarcoma cells.

Materials and methods: Osteosarcoma cell lines were treated with CAP with or without antioxidative agents and seeded in cell culture plates. Cell proliferation was determined by counting viable cells. Carrier gas-treated cells served as control. Peroxiredoxin (PRX) 1-3 expression and secretion were assessed.

Results: CAP treatment exhibited strongly attenuated proliferation rates. This effect was significantly attenuated by the addition of N-acetylcysteine (NAC). CAP-treated cells exhibited an increase of PRX 1 and 2 10 sec after treatment. The ratio of oxidized to reduced PRX1 and PRX2 was significantly altered with increasing cellular concentration of the oxidized dimer.

Conclusion: Antioxidant supplementation with NAC increases proliferation of CAP-treated osteosarcoma cells, implicating an involvement of redox signalling. Activation of PRX1 and -2 indicate CAP affects redox homeostasis.

Keywords: Osteosarcoma; antitumour efficacy; apoptosis; cold atmospheric plasma; peroxiredoxin.

MeSH terms

  • Apoptosis
  • Ascorbic Acid / chemistry
  • Atmosphere
  • Cell Line, Tumor
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic*
  • Homeostasis
  • Humans
  • Osteosarcoma / metabolism*
  • Oxidation-Reduction
  • Peroxiredoxins / metabolism*
  • Plasma Gases*
  • Protein Multimerization
  • Signal Transduction

Substances

  • Plasma Gases
  • PRDX1 protein, human
  • PRDX2 protein, human
  • Peroxiredoxins
  • Ascorbic Acid